Cargando…
Interleukin-17A-promoted MSC2 polarization related with new bone formation of ankylosing spondylitis
It’s still unknown how over-hyperplasia of tissue such like new bone formation (NBF) developed in ankylosing spondylitis (AS). We found low level of IL-17A promoted TLR4+MSC1 polarization with suppressed osteogenic differentiation through JAK2/STAT3 pathway, while high level of IL-17A promoted TLR3+...
Autores principales: | He, Tao, Huang, Yan, Zhang, Chen, Liu, Denghui, Cheng, Chao, Xu, Weidong, Zhang, Xiaoling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722540/ https://www.ncbi.nlm.nih.gov/pubmed/29228588 http://dx.doi.org/10.18632/oncotarget.20823 |
Ejemplares similares
-
Interleukin-17 Inhibitors for the Treatment of Ankylosing Spondylitis
por: Huang, Jin-Xian, et al.
Publicado: (2020) -
Neutrophil Extracellular Traps and Interleukin 17 in Ankylosing Spondylitis
por: Papagoras, Charalampos, et al.
Publicado: (2021) -
Aberrant upregulation of CaSR promotes pathological new bone formation in ankylosing spondylitis
por: Li, Xiang, et al.
Publicado: (2020) -
The relationship between inflammation and new bone formation in patients with ankylosing spondylitis
por: Baraliakos, Xenofon, et al.
Publicado: (2008) -
Maternal Interleukin-17 and disease activity influence pregnancy outcomes in women with psoriatic arthritis and ankylosing spondylitis
por: Girbash, Ehab F., et al.
Publicado: (2023)